Melatonin for Cancer
This is a very overlooked, alternative cancer prevention and treatment option with research behind it. At the very least consider it as an adjunct in cancer treatment.
Here is the study, along with study conclusions.
'Melatonin for the prevention and treatment of cancer'
Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503661/
CONCLUSIONS AND PROSPECTS The effects of melatonin on cancers have been widely studied, with a focus on hormone-dependent cancers.
Numerous experimental studies have indicated an oncostatic role of melatonin in various cancers, such as breast, ovarian, prostate, oral, gastric, and colorectal cancers.
The underlying mechanisms include several molecular pathways, which are associated with antioxidant activity, modulation of melatonin receptors MT1 and MT2, regulation of apoptosis, pro-survival signaling and tumor metabolism, inhibition of angiogenesis, invasion and metastasis, and induction of epigenetic alteration.
Melatonin also showed the potential to be utilized as adjuvant of cancer therapies, through reinforcing the therapeutic effects and reducing the side effects of chemotherapies or radiation.
In clinical trials, melatonin showed the ability to enhance the therapeutic effect of various anticancer drugs, and might help improving the sleep and life quality of cancer patients.
Overall, the impressive efficacy and safety of melatonin support it as a promising agent for the prevention and treatment of cancers. |